George Clinical is a leading Asia-Pacific contract research organization (CRO) that provides best-in-class services in clinical research. With over 20 years of experience, George Clinical has established itself as a global leader in the industry. The company specializes in a wide range of therapeutic areas including kidney & metabolic, oncology, cardiovascular, neurology, endocrinology, and respiratory.

George Clinical's scientific expertise sets it apart from other CROs. The company collaborates with renowned researchers and scientific leaders who have a proven track record in developing innovative treatment strategies for chronic diseases. This expertise allows George Clinical to design and execute effective clinical trials and accelerate patient recruitment.

In the field of oncology, George Clinical stands out for its access to global investigator networks, experienced project teams, and oncology experts. They are able to design and deliver oncology trials with the latest immunotherapies to the highest scientific standards. In cardiovascular research, George Clinical focuses on developing strategies for the prevention of heart diseases by targeting their primary risk factors such as high blood pressure and cholesterol, through drug and device interventions.

George Clinical also excels in the field of neurology, conducting studies on disorders that affect the brain, such as stroke, epilepsy, dementia, and sleep apnea. They have cultivated strong neurological investigator networks through participation in some of the largest clinical trials in the field. With a global presence spanning 39 locations and expertise in managing trials in up to 70 geographies, George Clinical is dedicated to improving the health of millions of people worldwide through clinical research.

They provide comprehensive clinical trial services to biopharmaceutical, medical device, and diagnostic customers, covering all phases, registration, and post-marketing trials